Compound 116
Identifiers
- Canonical SMILES:
CC(C)[C@@H]1CN(CCN1C(=O)C(=O)c1c[nH]c2cccc(F)c12)C(=O)c1ccccc1
- IUPAC name:
1-(4-benzoyl-2-propan-2-ylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione
- InChi:
InChI=1S/C24H24FN3O3/c1-15(2)20-14-27(23(30)16-7-4-3-5-8-16)11-12-28(20)24(31)22(29)17-13-26-19-10-6-9-18(25)21(17)19/h3-10,13,15,20,26H,11-12,14H2,1-2H3/t20-/m0/s1
- InChiKey:
UMIRVWYLVYLOHJ-FQEVSTJZSA-N
External links
45485526 |
24635300 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 6.33 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 421.18 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 3.60 | |||
TPSA | 73.48 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6954 | Talmapimod | DB05412 | |
0.6423 | LY-517717 | DB05713 | |
0.6260 | Indoramin | DB08950 | |
0.6014 | LTX-315 | DB12748 | |
0.6014 | Gramicidin D | DB00027 | |
0.5946 | Macimorelin | DB13074 | |
0.5940 | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | DB07953 | |
0.5933 | TC-6987 | DB14854 | |
0.5874 | Pruvanserin | DB13094 | |
0.5846 | N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID | DB07952 | |
0.5796 | Omiganan | DB06610 | |
0.5660 | BQ-123 | DB12054 | |
0.5613 | (S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide | DB04724 | |
0.5590 | Murepavadin | DB14777 | |
0.5577 | Ilomastat | DB02255 |